Effect L-Arginine and intravenous fluid Therapy in Oligohydramnios

Phase 2

Recruiting

• Conditions: Oligohydramnios.; Oligohydramnios; O41.0

• Registration Number: IRCT20160523028008N5
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Gestational age between 28 and 36 weeks
Single pregnancy
AFI less than 8 cm

Exclusion Criteria

Pregnancy with anomalies
Diabetes
Severe preeclampsia
Preterm Premature Rupture of Membranes (PPROM)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amniotic fluid index. Timepoint: One week after the intervention for up to 4 weeks. Method of measurement: Ultrasonography.

Secondary Outcome Measures

Name	Time	Method
eonatal Apgar score. Timepoint: At 1 and 5 minutes after birth. Method of measurement: Data sheets.;Neonatal weight. Timepoint: At birth. Method of measurement: Data sheets, gram.;Gestational Age at birth. Timepoint: At the end of the study. Method of measurement: Data sheets.